|
Symbol
|
RMAMHV | KYCWDU | OHTRCH | RMA2NV | CDKBKB | OSLRCH | KYUADU | OWRRCH | RMA6QV | KYZSDU | KYXXDU | ABICTQ | RMBQ5V | KZEHDU | PELRCH | MCAPJB | KZFDDU | ABRBTQ | RMBQBV | Z0AFFZ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Barrier Reverse Convertible |
|
Underlying
|
Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Pfizer Inc. | Eli Lilly & Co. / Merck & Co. Inc. | Eli Lilly / Merck & Co. / Pfizer | Eli Lilly / Johnson & Johnson / Pfizer | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly / Merck & Co. / Pfizer | Eli Lilly & Co. / Merck & Co. Inc. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche AG | Eli Lilly / Pfizer | Eli Lilly & Co. / Merck & Co. Inc. / Novo Nordisk AS (B) | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche AG / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS-SPONS ADR / Sandoz Group AG / Vertex Pharmaceuticals Inc. | Eli Lilly / Johnson & Johnson / Pfizer | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Eli Lilly & Co. / Johnson & Johnson / Pfizer Inc. / UnitedHealth Group Inc. | Eli Lilly & Co. / Johnson & Johnson / Merck & Co. Inc. / Pfizer Inc. |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
02.03.2026 | 05.06.2026 | 03.03.2026 | 23.06.2026 | 26.02.2026 | 19.08.2026 | 18.09.2026 | 20.03.2026 | 27.03.2026 | 23.04.2026 | 09.04.2026 | 05.05.2026 | 17.11.2026 | 20.11.2026 | 08.05.2026 | 21.05.2026 | 30.11.2026 | 10.06.2026 | 01.06.2026 | 16.06.2026 |
| Bid | 36.200 | - | 101.71 | 100.30 | - | 35.620 | - | 34.480 | 36.000 | - | - | 41.130 | 44.500 | - | 40.400 | - | - | 42.320 | 51.20 | - |
| Ask | - | - | - | 101.30 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |